We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J Faces GMP Transparency Suit, Recalls More Motrin
J&J Faces GMP Transparency Suit, Recalls More Motrin
January 3, 2012
A federal judge is allowing an investor lawsuit to move ahead against Johnson & Johnson (J&J) over its transparency on quality control failures that led to market withdrawals of Motrin and OTC children’s medications.